Ugeskrift for laeger
-
Restless legs syndrome (RLS) is a common disorder affecting more than 2% of adults. RLS is characterized by sensory-motor phenomena predominantly in the legs, but other body parts may be involved. The symptoms are most pronounced during rest and present a characteristic diurnal variation with maximum symptoms in the evening and at night. ⋯ RLS is present in an idiopathic and secondary form due to medical and other neurological diseases. Iron and DOPA are involved in the pathogenesis of the disease. The current best-documented treatment is partial dopamine-agonists and gabapentin.
-
Ugeskrift for laeger · Sep 2007
[Medical treatment of primary breast cancer: new targeted biological treatments].
The monoclonal antibody trastuzumab is at present the only modern targeted treatment which has been studied in early breast cancer. Data are available from four large and one smaller randomised trials where patients with HER2-positive operable breast cancer were randomised to trastuzumab or control in addition to standard adjuvant chemotherapy and endocrine treatment. Trastuzumab therapy resulted in relative risk reductions of 33-59% for recurrence and of 33-41% for death. Trastuzumab has become an integral part of adjuvant therapy in HER2-positive operable breast cancer.
-
For women with steroid receptor-positive breast cancers, endocrine therapy has proven to be a major component of adjuvant therapy reducing the risk of recurrence and death. The selective estrogen-receptor modulator (SERM) tamoxifen has been well established as safe and effective in the adjuvant care of both pre- and postmenopausal women. ⋯ Additionally, aromatase inhibitors have recently demonstrated further benefits in postmenopausal women. The ideal sequencing of treatment with tamoxifen and/or an aromatase inhibitor is the subject of several ongoing studies.